Condensed Interim Consolidated Financial Statements


For The Three and Nine Months Ended July 31, 2023








CLEARMIND MEDICINE INC....

Related Keywords

Tel Aviv , Israel , Toronto , Ontario , Canada , United States , Lillooet , British Columbia , Vancouver , Canadian , Israeli , Adi Zuloff Shani , Alan Rootenberg , Canadian Securities Exchange , Medigus Ltd , International Accounting Standards Board , Clearmindmed Ltd , Cyntar Ventures Inc , Company Israeli , Cyntar Ventures Inc The Company , Medigus Share Exchange , Party Transactions , Company Board Of Directors The , Share Exchange , Aegis Capital Corp , Clearmind Labs Corp , Scisparc Ltd , Nasdaq , International Financial Reporting Standards , Clearmind Medicine Inc , Foreign Exchange Rate Risk , Certain Of The Company , Nine Months Ended July , United States Dollars , Interim Consolidated Statements , Financial Position , Comprehensive Loss , Interim Statements , Shareholder Equity , Cash Flows , Cyntar Ventures , Clearmind Medicine , Lillooet Mining Divisions , Effective May , Nasdaq Capital Market , Presentation Currency , Foreign Currency , Unites States , Clearmind Labs , Accounting Estimates , Accounting Policies , Condensed Interim Consolidated Statements , Aegis Capital , Pre Funded Warrants , Pre Funded Warrant , Chief Scientific , Cash Financing , Condensed Interim Consolidated Statement , New Israeli Shekel , Risk Management , Exchange Rate Risk , Markets ,